Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.

about

A safety study of high concentration and high frequency intravitreal injection of conbercept in rabbits Effects of Ranibizumab and Aflibercept on Human Müller Cells and Photoreceptors under Stress Conditions.Simultaneous ex vivo functional testing of two retinas by in vivo electroretinogram system.

P2860

Q33674476-55AE7608-488B-41E0-A98A-ED56F189F316 Q37729097-7C618E6D-B14A-451E-8162-3A48B1C7DD44 Q41884009-6DCA1625-52C5-4421-8087-03CB17A0A58F

P2860

Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.

Item

http://www.wikidata.org/entity/Q45950125

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Electrophysiological toxicity ...... te retina organ culture model.

@en

Electrophysiological toxicity ...... te retina organ culture model.

@nl

type

Item

label

Electrophysiological toxicity ...... te retina organ culture model.

@en

Electrophysiological toxicity ...... te retina organ culture model.

@nl

prefLabel

Electrophysiological toxicity ...... te retina organ culture model.

@en

Electrophysiological toxicity ...... te retina organ culture model.

@nl

P1476

Electrophysiological toxicity ...... te retina organ culture model.

@en

P2093

Johanna Hofmann

http://www.w3.org/2001/XMLSchema#string

Kai Januschowski

http://www.w3.org/2001/XMLSchema#string

Karl-Ulrich Bartz-Schmidt

http://www.w3.org/2001/XMLSchema#string

Martin S Spitzer

http://www.w3.org/2001/XMLSchema#string

Matthias Lüke

http://www.w3.org/2001/XMLSchema#string

Peter Szurman

http://www.w3.org/2001/XMLSchema#string

Ulrike Hagemann

http://www.w3.org/2001/XMLSchema#string

Vanessa Koch

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab for neovascular age-related macular degeneration

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.

Ocular angiogenesis: the role of growth factors.

Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Environmental standardization: cure or cause of poor reproducibility in animal experiments?

Ranibizumab therapy for neovascular age-related macular degeneration.

P304

e305-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AOS.12300

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sven Schnichels

Sabine Aisenbrey

P577

2013-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24206925

http://www.w3.org/2001/XMLSchema#string

P921

electrophysiology

Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.

about

P2860

P2860

Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921